"In-Quest Medical Research is a multi-specialty clinical research facility specializing in Phase II-IV clinical trials. *Saturday and Sunday by appointment only"

During the past decade, In-Quest Medical Research, LLC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "In-Quest Medical Research, LLC" #1 sponsor was "Pfizer" with 3 trials, followed by "Phathom Pharmaceuticals, Inc." with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored and "BioDelivery Sciences International" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "In-Quest Medical Research, LLC" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "In-Quest Medical Research, LLC" are "Cardiovascular Disease" (2 trials), "Heartburn" (2 trials), "Low Back Pain" (2 trials), "Non-Erosive Gastro-Esophageal Reflux Disease" (2 trials) and "Overactive Bladder" (2 trials). Many other conditions were trialed in "In-Quest Medical Research, LLC" in a lesser frequency.

Most popular intervention types in "In-Quest Medical Research, LLC" are "Drug" (17 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Vonoprazan" (3 trials), "Dapagliflozin" (2 trials), "Tolterodine Tartrate ER" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "In-Quest Medical Research, LLC" are 18 trials for "All" genders.

Currently, there are NaN active trials in "In-Quest Medical Research, LLC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in In-Quest Medical Research, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in In-Quest Medical Research, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".